CYTIDINE-5-CARBOXAMIDE MODIFIED NUCLEOTIDE COMPOSITIONS AND METHODS RELATED THERETO

To provide 5-position modified cytosines and phosphoramidites thereof, and triphosphate derivatives thereof, and methods of making and using the same, and compositions and uses of the modified nucleosides as part of a nucleic acid molecule (e.g., aptamer).SOLUTION: The present disclosure provides a...

Full description

Saved in:
Bibliographic Details
Main Authors NEBOJSA JANJIC, BHARAT NATHU GAWANDE, JOHN ROHLOFF
Format Patent
LanguageEnglish
Japanese
Published 13.05.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To provide 5-position modified cytosines and phosphoramidites thereof, and triphosphate derivatives thereof, and methods of making and using the same, and compositions and uses of the modified nucleosides as part of a nucleic acid molecule (e.g., aptamer).SOLUTION: The present disclosure provides a compound having a structure represented by the following formula I. (R independently represents -(CH2) n-, n is an integer of 0-10; R' is independently selected from the group consisting of -H, -OAc, -OBz, -P(NiPr2)(OCH2CH2CN), and -OSiMe2 tBu; R'' is independently selected from the group consisting of hydrogen, 4,4'-dimethoxytrityl (DMT) and triphosphate (-P(O)(OH)-O-P(O)(OH)-O-P(O)(OH)2) or a salt thereof).SELECTED DRAWING: None 【課題】5位修飾シトシン及びそのホスホルアミダイト、ならびにトリホスフェート誘導体、それの製造及び使用方法、及び核酸分子(例えば、アプタマー)の一部としての組成物ならびに修飾ヌクレオシドの使用を提供する。【解決手段】下記式Iに示される構造を含む化合物。(Rは独立して−(CH2)n−であって、nは0〜10の整数であり;R'は−H、−OAc、−OBz、−P(NiPr2)(OCH2CH2CN)、及び−OSiMe2tBuから成る群から独立して選択され;R''は水素、4,4'−ジメトキシトリチル(DMT)及びトリホスフェート(−P(O)(OH)−O−P(O)(OH)−O−P(O)(OH)2)またはそれらの塩から成る群から独立して選択される。)【選択図】なし
AbstractList To provide 5-position modified cytosines and phosphoramidites thereof, and triphosphate derivatives thereof, and methods of making and using the same, and compositions and uses of the modified nucleosides as part of a nucleic acid molecule (e.g., aptamer).SOLUTION: The present disclosure provides a compound having a structure represented by the following formula I. (R independently represents -(CH2) n-, n is an integer of 0-10; R' is independently selected from the group consisting of -H, -OAc, -OBz, -P(NiPr2)(OCH2CH2CN), and -OSiMe2 tBu; R'' is independently selected from the group consisting of hydrogen, 4,4'-dimethoxytrityl (DMT) and triphosphate (-P(O)(OH)-O-P(O)(OH)-O-P(O)(OH)2) or a salt thereof).SELECTED DRAWING: None 【課題】5位修飾シトシン及びそのホスホルアミダイト、ならびにトリホスフェート誘導体、それの製造及び使用方法、及び核酸分子(例えば、アプタマー)の一部としての組成物ならびに修飾ヌクレオシドの使用を提供する。【解決手段】下記式Iに示される構造を含む化合物。(Rは独立して−(CH2)n−であって、nは0〜10の整数であり;R'は−H、−OAc、−OBz、−P(NiPr2)(OCH2CH2CN)、及び−OSiMe2tBuから成る群から独立して選択され;R''は水素、4,4'−ジメトキシトリチル(DMT)及びトリホスフェート(−P(O)(OH)−O−P(O)(OH)−O−P(O)(OH)2)またはそれらの塩から成る群から独立して選択される。)【選択図】なし
Author JOHN ROHLOFF
NEBOJSA JANJIC
BHARAT NATHU GAWANDE
Author_xml – fullname: NEBOJSA JANJIC
– fullname: BHARAT NATHU GAWANDE
– fullname: JOHN ROHLOFF
BookMark eNqNyk0KwjAQQOEsdOHfHYL7QNMirmMypSNNpjQj6KoUiStpC_X-qOABXD14fGuxGMYhrUS0N0aHAdRBWdOe6Go8OpCeHJYIToaLrYH4-yz5hiIyUojSBCc9cEUuyhZqwx_LFbTAtBXLR_-c0-7XjdiXwLZSaRq7NE_9PQ3p1Z2bPMt1dixyrU3xF3oDnqIyEA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate シチジン−5−カルボキサミド修飾ヌクレオチド組成物及びそれに関連する方法
ExternalDocumentID JP2021073211A
GroupedDBID EVB
ID FETCH-epo_espacenet_JP2021073211A3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:51:13 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Japanese
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_JP2021073211A3
Notes Application Number: JP20210002566
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210513&DB=EPODOC&CC=JP&NR=2021073211A
ParticipantIDs epo_espacenet_JP2021073211A
PublicationCentury 2000
PublicationDate 20210513
PublicationDateYYYYMMDD 2021-05-13
PublicationDate_xml – month: 05
  year: 2021
  text: 20210513
  day: 13
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies SOMALOGIC INC
RelatedCompanies_xml – name: SOMALOGIC INC
Score 3.4599235
Snippet To provide 5-position modified cytosines and phosphoramidites thereof, and triphosphate derivatives thereof, and methods of making and using the same, and...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
COMPOSITIONS THEREOF
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
CULTURE MEDIA
DERIVATIVES THEREOF
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES OF PREPARING SUCH COMPOSITIONS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
SUGARS
VINEGAR
WINE
Title CYTIDINE-5-CARBOXAMIDE MODIFIED NUCLEOTIDE COMPOSITIONS AND METHODS RELATED THERETO
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210513&DB=EPODOC&locale=&CC=JP&NR=2021073211A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp6JOJYj0rbh-bexhSJektMM2ZctkPo1-DVTYhqv473upm-5pb0kOQnJwv8vlcr8APHSKpG0kmaHnxSzRbQdjVoWBejZrmalygKapCpzDqO2P7cHEmdTgY1MLU_GEflfkiGhRGdp7WeH18v8Si1VvK1eP6RsOLZ482WPaOjrG-MUxLI31ezwWTFCN0t4g1qLhr6xjYbjj7sG-Okcron3-0ldlKcttn-KdwEGM083LU6i9Jw04opuv1xpwGK4z3thcG9_qDEb0VQYsiLju6NQd9sXEDQPGSShY4AWckWhMn7mQaoyKMBajoKoRJm7ESMilL9iIqC8yEKyI9PmQS3EO9x6X1NdxddM_XUwH8dZOrAuozxfz4hJIRzHBtexUUXoh9mWpXZh4uMjzvGsUeda9guaOia53SptwrHoqZ25YN1AvP7-KW3TFZXpXqfAHGAWE-A
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFOebTkWdH0Wkb8X1a2UPQ9okpZ1rU7ZM5tPo10CFbbiK_75J3HRPewt3cCQHd5dfLncH8OCUaUdPc10rylmqWTbHrMIHavmsbWQiABqGKHCO4k4wtvoTe1KDj00tjOwT-i2bI3KLyrm9V9JfL_8fsbD8W7l6zN44afHksx5W1-iY4xdbN1Xs9UhCMUUqQr1-osbDX55jcrjj7sG-wzGhxEovnihLWW7HFP8YDhIubl6dQO09bUIDbUavNeEwWme8-XJtfKtTGKFXFuIwJpqtIXfo0YkbhZgoEcWhHxKsxGM0IJQJGqJRQkehrBFW3BgrEWEBxSNFjMjgzkphARkSRs_g3icMBRrf3fRPF9N-snUS8xzq88W8vADFEZ3g2lYmWnpx35dnVmnwy0VRFF29LPLuJbR2CLrayb2DRsCiwXQQxs8tOBIckT_XzWuoV59f5Q0Py1V2K9X5A3Tzh-I
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CYTIDINE-5-CARBOXAMIDE+MODIFIED+NUCLEOTIDE+COMPOSITIONS+AND+METHODS+RELATED+THERETO&rft.inventor=NEBOJSA+JANJIC&rft.inventor=BHARAT+NATHU+GAWANDE&rft.inventor=JOHN+ROHLOFF&rft.date=2021-05-13&rft.externalDBID=A&rft.externalDocID=JP2021073211A